-
1
-
-
0032745094
-
Inflammatory mechanisms in neonatal chronic lung disease
-
Speer CP. Inflammatory mechanisms in neonatal chronic lung disease. Eur J Pediatr 1999; 158 Suppl 1: S18-22.
-
(1999)
Eur J Pediatr
, vol.158
, Issue.SUPPL. 1
-
-
Speer, C.P.1
-
2
-
-
0029811022
-
Early production of macrophage inflammatory protein 1α occurs in respiratory distress syndrome and is associated with poor outcome
-
Murch SH, Costeloe K, Klein NJ, MacDonald TT. Early production of macrophage inflammatory protein 1α occurs in respiratory distress syndrome and is associated with poor outcome. Pediatr Res 1996; 40: 490-7.
-
(1996)
Pediatr Res
, vol.40
, pp. 490-497
-
-
Murch, S.H.1
Costeloe, K.2
Klein, N.J.3
MacDonald, T.T.4
-
3
-
-
0028849626
-
Studies of the release and turnover of a human neutrophil lipocalin
-
Axelsson L, Bergenfeldt M, Ohlsson K. Studies of the release and turnover of a human neutrophil lipocalin. Scand J Clin Lab Invest 1995; 55: 577-88.
-
(1995)
Scand J Clin Lab Invest
, vol.55
, pp. 577-588
-
-
Axelsson, L.1
Bergenfeldt, M.2
Ohlsson, K.3
-
4
-
-
0015764673
-
Acute pulmonary X-ray changes in hyaline membrane disease treated with artificial ventilation and positive end expiratory pressure
-
Giedion A, Haefliger H, Dangel P. Acute pulmonary X-ray changes in hyaline membrane disease treated with artificial ventilation and positive end expiratory pressure. Pediatr Radiol 1973; 1: 145-52.
-
(1973)
Pediatr Radiol
, vol.1
, pp. 145-152
-
-
Giedion, A.1
Haefliger, H.2
Dangel, P.3
-
5
-
-
0028223591
-
The development of an assay for human neutrophil lipocalin (HNL) to be used as a specific marker of neutrophil activity in vivo and vitro
-
Xu SY, Petersson CG, Carlsson M, Venge P. The development of an assay for human neutrophil lipocalin (HNL) to be used as a specific marker of neutrophil activity in vivo and vitro. J Immunol Methods 1994; 171: 245-52.
-
(1994)
J Immunol Methods
, vol.171
, pp. 245-252
-
-
Xu, S.Y.1
Petersson, C.G.2
Carlsson, M.3
Venge, P.4
-
6
-
-
0026621989
-
Release of neutrophil proteinase 4(3) and leukocyte elastase during phagocytosis and their interaction with proteinase inhibitors
-
Bergenfeldt M, Axelsson L, Ohlsson K. Release of neutrophil proteinase 4(3) and leukocyte elastase during phagocytosis and their interaction with proteinase inhibitors. Scand J Clin Lab Invest 1992; 52: 823-9.
-
(1992)
Scand J Clin Lab Invest
, vol.52
, pp. 823-829
-
-
Bergenfeldt, M.1
Axelsson, L.2
Ohlsson, K.3
-
7
-
-
0026012071
-
Release of immunoreactive human neutrophil proteinase 4, normally and in peritonitis
-
Lundberg E, Bergenfeldt M, Ohlsson K. Release of immunoreactive human neutrophil proteinase 4, normally and in peritonitis. Scand J Clin Lab Invest 1991; 51: 23-9.
-
(1991)
Scand J Clin Lab Invest
, vol.51
, pp. 23-29
-
-
Lundberg, E.1
Bergenfeldt, M.2
Ohlsson, K.3
-
8
-
-
0031593637
-
2-macroglobulin and low neutrophil lipocalin and elastase levels in plasma
-
2-macroglobulin and low neutrophil lipocalin and elastase levels in plasma. Pediatr Res 1998; 44: 939-41.
-
(1998)
Pediatr Res
, vol.44
, pp. 939-941
-
-
Sveger, T.1
Ohlsson, K.2
Piitulainen, E.3
-
9
-
-
0027441749
-
Protease-antiprotease levels and whole-blood chemiluminescence in acute peritonitis
-
Bergenfelt M, Ohlsson K. Protease-antiprotease levels and whole-blood chemiluminescence in acute peritonitis. Gastroenterol Jpn 1993; 28: 687-98.
-
(1993)
Gastroenterol Jpn
, vol.28
, pp. 687-698
-
-
Bergenfelt, M.1
Ohlsson, K.2
-
10
-
-
0033844840
-
Diagnostic potential of neutrophil elastase inhibitor complex in the routine care of critically ill newborn infants
-
Fischer JE, Brunner A, Janosek M, Nadal D, Blau N, Fanconi S. Diagnostic potential of neutrophil elastase inhibitor complex in the routine care of critically ill newborn infants. Eur J Pediatr 2000; 159: 659-62.
-
(2000)
Eur J Pediatr
, vol.159
, pp. 659-662
-
-
Fischer, J.E.1
Brunner, A.2
Janosek, M.3
Nadal, D.4
Blau, N.5
Fanconi, S.6
-
11
-
-
6844254553
-
1-proteinase inhibitor therapy for the prevention of chronic lung disease of prematurity: A randomized controlled trial
-
1-proteinase inhibitor therapy for the prevention of chronic lung disease of prematurity: a randomized controlled trial. Pediatrics 1998; 101: 89-94.
-
(1998)
Pediatrics
, vol.101
, pp. 89-94
-
-
Stiskal, J.A.1
Dunn, M.S.2
Sherman, A.T.3
O'Brien, K.K.4
Kelly, K.N.5
Koppel, R.J.6
Cox, D.W.7
Ito, S.8
Chappel, S.L.9
Rabinovitch, M.10
-
12
-
-
0028210775
-
Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: A sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates
-
Groneck P, Gotze-Speer B, Oppremann M, Eiffert H, Speer CP. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics 1991; 93: 712-8.
-
(1991)
Pediatrics
, vol.93
, pp. 712-718
-
-
Groneck, P.1
Gotze-Speer, B.2
Oppremann, M.3
Eiffert, H.4
Speer, C.P.5
-
13
-
-
0034876437
-
Matrix metalloproteinases-2, -8 and -9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress
-
Cederqvist K, Sorsa T, Tervahartiala T, Maisi P, Reunanen K, Lassus P, Andersson S. Matrix metalloproteinases-2, -8 and -9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress. Pediatrics 2001; 108: 686-92.
-
(2001)
Pediatrics
, vol.108
, pp. 686-692
-
-
Cederqvist, K.1
Sorsa, T.2
Tervahartiala, T.3
Maisi, P.4
Reunanen, K.5
Lassus, P.6
Andersson, S.7
|